Evidence map›Paper›PMID 30054480›Full record

ArticleNature communications2018

Neutrophil extracellular trap formation requires OPA1-dependent glycolytic ATP production.

Poorya Amini, Darko Stojkov, Andrea Felser, Christopher B Jackson, Carolina Courage, André Schaller, Laurent Gelman, Maria Eugenia Soriano, Jean-Marc Nuoffer, Luca Scorrano and 3 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 124 papers.

0numbers the graph read from it
0cells of the map it votes in
124citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

124 citing papers in PubMed, 180 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Metabolic Reprogramming and ILC2 Plasticity in Obesity-related Asthma.Clinical reviews in allergy & immunology · 2026
    Review
  9. Review
  10. Balancing inflammation and regeneration: immune cell dynamics in nerve repair: a comprehensive review.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Frontiers in immunology · 2026
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

64 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 3 countries.

Poorya AminiInstitute of Pharmacology, University of Bern, 3010, Bern, Switzerland.
Darko StojkovInstitute of Pharmacology, University of Bern, 3010, Bern, Switzerland.
Andrea FelserUniversity Institute of Clinical Chemistry, Bern University Hospital, 3010, Bern, Switzerland.ORCID http://orcid.org/0000-0003-4806-2940
Christopher B JacksonResearch Program for Molecular Neurology, Biomedicum Helsinki, University of Helsinki, 00290, Helsinki, Finland.ORCID http://orcid.org/0000-0003-1035-6417
Carolina CourageDivision of Human Genetics and Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, 3010, Bern, Switzerland.
André SchallerDivision of Human Genetics and Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, 3010, Bern, Switzerland.ORCID http://orcid.org/0000-0001-5174-5764
Laurent GelmanFriedrich Miescher Institute for Biomedical Research, 4058, Basel, Switzerland.
Maria Eugenia SorianoDepartment of Biology, University of Padua, 35121, Padua, Italy.ORCID http://orcid.org/0000-0002-7971-2961
Jean-Marc NuofferUniversity Institute of Clinical Chemistry, Bern University Hospital, 3010, Bern, Switzerland.ORCID http://orcid.org/0000-0003-3650-6153
Luca ScorranoVenetian Institute of Molecular Medicine (VIMM), 35129, Padua, Italy.ORCID http://orcid.org/0000-0002-8515-8928
Charaf BenarafaInstitute of Virology and Immunology, 3147, Mittelhäusern, Switzerland.ORCID http://orcid.org/0000-0002-2049-7769
Shida YousefiInstitute of Pharmacology, University of Bern, 3010, Bern, Switzerland.ORCID http://orcid.org/0000-0002-9855-4305
Hans-Uwe SimonInstitute of Pharmacology, University of Bern, 3010, Bern, Switzerland. hus@pki.unibe.ch.ORCID http://orcid.org/0000-0002-9404-7736
University of Bern · CHUniversity Hospital of Bern · CHFriedrich Miescher Institute · CHUniversity of Helsinki · FIUniversity of Padua · ITVeneto Institute of Molecular Medicine · IT

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) 310030_166473
6 · The paper itself

Abstract

Optic atrophy 1 (OPA1) is a mitochondrial inner membrane protein that has an important role in mitochondrial fusion and structural integrity. Dysfunctional OPA1 mutations cause atrophy of the optic nerve leading to blindness. Here, we show that OPA1 has an important role in the innate immune system. Using conditional knockout mice lacking Opa1 in neutrophils (Opa1

Indexed as

ActinsAdenosine TriphosphateAnimalsAnti-Bacterial AgentsBone MarrowCell Line, TumorElectron Transport Complex IExtracellular TrapsGene Expression ProfilingGlycolysisGTP PhosphohydrolasesHumansImmunity, InnateLungMiceMice, KnockoutActinsAdenosine TriphosphateAnti-Bacterial AgentsElectron Transport Complex IGTP PhosphohydrolasesOpa1 protein, mouseReactive Oxygen Species

Identifiers

PMID30054480
PMCPMC6063938
OpenAlexW2883240788

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.